Supplementary Data from Nanoparticle-based combination therapy enhances fulvestrant efficacy and overcomes tumor resistance in ER-positive breast cancer

Authors:

Open Access

Publisher website

16 September 2024

other
Published by American Association for Cancer Research (AACR)

DOI:10.1158/0008-5472.27028264

Abstract

Supporting information for manuscript

Keywords